# Cellbyte

> Cellbyte is the AI-native platform for pharmaceutical Pricing & Market Access (P&MA). Built in Munich by Cellbyte GmbH, it turns weeks of manual market access research into cited, defensible answers in minutes, and pairs the platform with senior market access experts who deliver project work on it.

Cellbyte serves Pricing & Market Access, HEOR and launch teams at pharma and biotech companies and the consultancies that support them. The platform brings 100+ trusted sources and 30 million+ data points together in one unified intelligence layer, with page-level citations for every figure. Cellbyte GmbH is ISO/IEC 27001:2022 certified, hosts customer data in the EU, and publishes its security posture at https://trust.cellbyte.com.

## Main pages

- [Home](https://www.cellbyte.com/): Turn weeks of manual research into answers in minutes. Powered by AI agents, backed by experts.
- [Platform](https://www.cellbyte.com/platform): The AI-native platform, purpose-built for Pricing & Market Access. From question to a defensible assessment in minutes, with every figure traceable to the source line.
- [Services](https://www.cellbyte.com/services): The future of Market Access strategy. Senior Pricing & Market Access judgement, powered by AI agents.
- [Customers](https://www.cellbyte.com/customers): Trusted by teams at leading life sciences companies. 8 of the top 20 pharma companies use Cellbyte.
- [Security](https://www.cellbyte.com/security): Enterprise-grade security, built for pharma. ISO/IEC 27001:2022 certified, EU data residency, and confidentiality on every layer.
- [Company](https://www.cellbyte.com/company): We're on a mission to accelerate global drug launches. Meet the founders, advisors and investors behind Cellbyte.

## Get in touch

- [Book a demo](https://www.cellbyte.com/book-a-demo): Request a live platform walkthrough built around your disease areas and markets.
- [Scope your project](https://www.cellbyte.com/scope-your-project): Describe the challenge you're facing and the markets in scope. We'll arrange a call with one of our market access experts.
- [Contact](https://www.cellbyte.com/contact): Get in touch with Cellbyte. General enquiries, press and security contacts. Email: info@cellbyte.com

## News

- [Blog](https://www.cellbyte.com/blog): Product updates, press releases and news from Cellbyte. RSS: https://www.cellbyte.com/blog/rss.xml
- [Introducing Cellbyte 2.0](https://www.cellbyte.com/blog/introducing-cellbyte-2-0.md): Cellbyte now covers your Pricing and Market Access work end to end, from your first question through to the report, and updates you when new evidence arrives. (19 October 2026)
- [Cellbyte raises $2.75 million to cut pharmaceutical drug launch timelines in half with AI](https://www.cellbyte.com/blog/seed-round.md): Frontline Ventures leads seed round to accelerate Cellbyte's international expansion, triple its headcount and automate more drug launch workflows. (18 November 2025)

## Other

- [Trust Center](https://trust.cellbyte.com): Security certifications, policies and sub-processors.
- [Platform login](https://app.cellbyte.com): For existing customers.
- [Imprint](https://www.cellbyte.com/legal/imprint): Legal information about Cellbyte GmbH, Munich.
- [Terms and Conditions](https://www.cellbyte.com/legal/terms): Terms and Conditions governing the use of the Cellbyte platform and services.
- [Privacy Policy](https://www.cellbyte.com/legal/privacy-policy): How Cellbyte collects, uses and protects your personal data.